The Globe

Do Co-Medications Cut Immunotherapy Benefit in Lung Cancer?

Source link : https://newshealth.biz/health-news/do-co-medications-cut-immunotherapy-benefit-in-lung-cancer/

Patients with advanced lung cancer receiving pembrolizumab have worse survival when exposed to certain antibiotics, high-dose steroids, or proton pump inhibitors. Medscape Medical News Source link : https://www.medscape.com/viewarticle/do-co-medications-cut-immunotherapy-benefit-lung-cancer-2025a1000o6r?src=rss Author : Publish date : 2025-09-12 10:45:00 Copyright for syndicated content belongs to the linked Source.

The post Do Co-Medications Cut Immunotherapy Benefit in Lung Cancer? first appeared on News Health.

—-

Author : News Health

Publish date : 2025-09-12 10:45:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version